# Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL

> **NCT06289959** · NA · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Soochow University** · enrollment: 30 (estimated)

## Conditions studied

- Lymphoma, Large B-Cell, Diffuse

## Interventions

- **DIAGNOSTIC_TEST:** cfDNA

## Key facts

- **NCT ID:** NCT06289959
- **Lead sponsor:** Second Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-02-25
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06289959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06289959, "Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06289959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*